GB
Ginkgo Bioworks Holdings
🇺🇸XNYS.DNAUnited StatesHealthcare
$7.08USDup +0.07 (+1%)OpenEnd of day5:17 PM
Price$7.08+0.07 (+1%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- New York Stock Exchange . XNYS
- Type
- Stock
- ISIN
- US37611X2099
- CUSIP
- 37611X100
Company
- Employees
- 485
- Headquarters
- Boston, United States
- Website
- https://www.ginkgo.bio
- CEO
- Dr. Jason Kelly Ph.D.
Market
- Shares outstanding
- 55.4M
- Market cap
- $392.12M
Key dates
- Next earnings
- Nov 5, 2026
Highlights
- Market cap
- $392.12M
- EPS LTM
- -$5.25calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -1.35calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $111.86M-51.54%down year on year
- Net income
- -$290.8M+7.74%up year on year
- Gross margin
- 80.09%+0.29%up year on year
- Free cash flow
- -$190.12M+30.66%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.